美托洛尔联合苓桂术甘汤治疗冠心病心律失常的效果分析  

Metoprolol joint Lingguizhugantang in treatment of coronary heart disease arrhythmias effect analysis

作　　者：郑和豪[1] 方琪[1] 董嘉毅[2] 

机构地区：[1]浙江省衢州市人民医院,浙江衢州324000 [2]东南大学附属中大医院,江苏南京210009

出　　处：《中国现代医生》2013年第15期58-60,共3页China Modern Doctor

基　　金：2010年江苏省卫生厅项目(H201032)

摘　　要：目的进一步分析美托洛尔联合苓桂术甘汤对冠心病心律失常的效果。方法随机抽取2011年1月-2012年1月到衢州市人民医院进行治疗的128例冠心病心律失常患者,并把这些患者进行编号,单数为观察组,双数为对照组,每组患者64例。对照组主要采用美托洛尔作为治疗的药物,观察组则在对照组的基础之上联合苓桂术甘汤进行治疗,治疗时间都为4周。最后再把两组的治疗效果进行对比。结果对照组的总体有效率为60.94%,而观察组的总体有效率高达96.12%(P<0.05);在治疗过程中,观察组患者出现的房性早搏、室性早搏和房室交界性的早搏等情况的次数均要明显比对照组少(P<0.05),所以这两组数据结果都具有统计学意义。结论美托洛尔联合苓桂术甘汤在冠心病心律失常的治疗中效果明显高于单纯使用美托洛尔治疗,这对于临床治疗冠心病心律失常具有良好的借鉴意义。Objective To further analyze metoprolol Lingguizhugantang effect on coronary heart disease arrhythmias. Methods A total of 128 cases were selected from January 2011 to January 2012 in Quzhou city people＇s Hospital of coronary heart disease patients with cardiac arrhythmias, and these patients are numbered, singular in the observation group, double the number for the control group, each group of 64 patients. Control group were given using metoprolol as treatment drug, and the observation group in the control group based on the joint lingguizhu gantang for treatment, treatment for 4 weeks. And finally the curative effect were compared. Results Control group, the overall effective rate was 60.94%, and observe group＇s overall efficiency was up to 96.12% （P 〈 0.05）; observation group of patients in the treatment process, atrial premature beats, premature ventricular contractions and atrioventricular junctionthe hum ber of premature beats, etc. to be significantly less than the control group （P 〈 0.05）, the results of these two sets of data are statistically significant. Conclusion The effect of metoprolol lingguizhu gantang in which the treatment of coronary heart disease arrhythmia was significantly higher than the simple use of metoprolol, which has a good reference for the clinical treatment of coronary heart disease, arrhythmia.

关 键 词：苓桂术甘汤 美托洛尔 冠心病 心律失常 

分 类 号：R259[医药卫生—中西医结合]